Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Center for Lymphoma, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Cancer. 2020 Feb 1;126(3):515-522. doi: 10.1002/cncr.32549. Epub 2019 Oct 8.
Patients with blood cancers experience high-intensity medical care near the end of life (EOL) and low rates of hospice use; attributes of goals of care (GOC) discussions may partly explain these outcomes.
By using a retrospective cohort of patients with blood cancer who received care at Dana-Farber Cancer Institute and died in 2014, the authors assessed the potential relationship between timing, location, and the involvement of hematologic oncologists in the first GOC discussion with intensity of care near the EOL and timely hospice use.
Among 383 patients, 39.2% had leukemia/myelodysplastic syndromes, 37.1% had lymphoma, and 23.7% had myeloma. Overall, 65.3% of patients had a documented GOC discussion. Of the first discussions, 33.2% occurred >30 days before death, 34.8% occurred in the outpatient setting, and 46.4% included a hematologic oncologist. In multivariable analyses, having the first discussion >30 days before death (odds ratio [OR], 0.37; 95% CI, 0.17-0.81), in the outpatient setting (OR, 0.21; 95% CI, 0.09-0.50), and having a hematologic oncologist present (OR, 0.40; 95% CI, 0.21-0.77) were associated with lower odds of intensive care unit admission ≤30 days before death. The presence of a hematologic oncologist at the first discussion (OR, 3.07; 95% CI, 1.58-5.96) also was associated with earlier hospice use (>3 days before death).
In this large cohort of blood cancer decedents, most initial GOC discussions occurred close to death and in the inpatient setting. When discussions were timely, outpatient, or involved hematologic oncologists, patients were less likely to experience intensive health care use near death and were more likely to enroll in hospice.
患有血液癌的患者在生命末期(EOL)接受高强度的医疗护理,但使用临终关怀的比例较低;目标关怀(GOC)讨论的属性可能部分解释了这些结果。
通过使用在达纳-法伯癌症研究所接受治疗并于 2014 年去世的血液癌患者的回顾性队列,作者评估了首次 GOC 讨论的时间、地点和血液肿瘤学家的参与与 EOL 附近护理强度和及时使用临终关怀之间的潜在关系。
在 383 名患者中,39.2%患有白血病/骨髓增生异常综合征,37.1%患有淋巴瘤,23.7%患有骨髓瘤。总体而言,65.3%的患者有记录的 GOC 讨论。在首次讨论中,33.2%发生在死亡前 30 天以上,34.8%发生在门诊,46.4%包括血液肿瘤学家。在多变量分析中,首次讨论发生在死亡前 30 天以上(比值比[OR],0.37;95%CI,0.17-0.81)、在门诊(OR,0.21;95%CI,0.09-0.50)和有血液肿瘤学家在场(OR,0.40;95%CI,0.21-0.77)与在死亡前 30 天内入住重症监护病房的可能性较低相关。首次讨论中有血液肿瘤学家(OR,3.07;95%CI,1.58-5.96)也与更早地使用临终关怀(>死亡前 3 天)相关。
在这个大型血液癌死亡患者队列中,大多数初始 GOC 讨论发生在接近死亡和住院环境中。当讨论及时、门诊或涉及血液肿瘤学家时,患者在死亡前经历高强度医疗护理的可能性较低,并且更有可能接受临终关怀。